Provided by Tiger Trade Technology Pte. Ltd.

EDDING GENOR

3.210
+0.0300.94%
Volume:1.42M
Turnover:4.56M
Market Cap:6.43B
PE:-32.15
High:3.240
Open:3.180
Low:3.170
Close:3.180
52wk High:5.600
52wk Low:1.710
Shares:2.00B
HK Float Shares:2.00B
Volume Ratio:1.23
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.100
ROE:2.56%
ROA:1.50%
PB:5.15
PE(LYR):-32.15
PS:25.28

Loading ...

Company Profile

Company Name:
EDDING GENOR
Exchange:
SEHK
Establishment Date:
2001
Employees:
- -
Office Location:
Building 1,Room 406,No. 36 Doukou Road,Hengqin New Area,Zhuhai,Guangdong Province,China
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Edding Genor Group Holdings Ltd, formerly Genor Biopharma Holdings Ltd, is a company primarily engaged in the biopharmaceuticals business. The Company’s main business is engaged in the discovery, development and commercialization of biopharmaceutical products for human use. The Company’s product pipelines include Lerociclib (GB491), GB261, GB263T, Infliximab (GB242), Coprelotamab (GB221), GB223, Rituximab (GB241) and other products, covering disease fields such as breast cancer, lung cancer, gastrointestinal tumors, and blood tumors. The Company mainly conducts its businesses in the domestic market.

Directors

Name
Position
Ni Xin
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
DI Jing
Executive Director
WEN CHEN
Independent Director,Member of the Remuneration and Assessment Committee
XU Qing
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
ZHENG Jing Jing
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
YU Tie Ming
Director,Audit Committee Member
David Guowei Wang
Director,Member of the Remuneration and Assessment Committee

Shareholders

Name
Position
GUO Feng
CEO
Ni Xin
General Manager
WENG Cheng Yi
CFO,Board Secretary
LIANG Qi Bin
CTO
DI Jing
Corporate Secretary,Other Senior Executives
XIE Cui Mei
Corporate Secretary
LI Tong
Other Senior Executives